DCBLD2 and colorectal carcinoma: To identify robust biomarkers associated with CRC prognosis that can be validated in our two libraries of tissues, we used the ranking reported in the third step of gSFA and the resulting genes are shown in Table S1, where AKAP12, DCBLD2, NT5E were the most common genes selected by the algorithm in the various signatures.